Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
In what ways has the generic option influenced ruxolitinib's market share?Tenofovir generic patent?When will tenofovir alafenide come off patent in canada?When is the expected fda decision date for apotex's ruxolitinib resubmission?Dabrafenib mesylate when the patent is expiring in india?
See the DrugPatentWatch profile for warfarin
Warfarin and Lipitor (atorvastatin) have no direct pharmacokinetic interaction. Atorvastatin does not significantly affect warfarin's metabolism via CYP enzymes, and warfarin does not alter atorvastatin levels.[1][2]
Both drugs increase bleeding risk independently—warfarin as an anticoagulant and atorvastatin via rare muscle effects that could worsen falls or injuries. No clinical studies show amplified bleeding when combined, but monitoring INR (international normalized ratio) is standard for warfarin users starting statins.[1][3]
Guidelines recommend baseline INR check before adding atorvastatin, then recheck 5-7 days later. Dose adjustments to warfarin are rare but possible if INR shifts >0.5 from baseline. Patient education on bruising/bleeding signs applies.[2][4]
Atorvastatin has lower interaction risk than lovastatin or simvastatin, which compete more with warfarin's CYP2C9 pathway. Pravastatin or rosuvastatin are even safer alternatives for warfarin patients.[1][3]
A large cohort analysis found no excess adverse events with atorvastatin-warfarin vs. other statins. Case reports of INR changes exist but are inconsistent and not causal.[2][5] Sources [1] Drugs.com: Atorvastatin and Warfarin Interaction [2] Medscape: Statin-Anticoagulant Interactions [3] UpToDate: Drug Interactions with Warfarin [4] American College of Cardiology: Statin Safety in Anticoagulated Patients [5] PubMed: Statins and Warfarin Outcomes
Other Questions About Warfarin :